Patented Medicine Prices Review Board
Symbol of the Government of Canada
Skip to content | Skip to institutional links

Common menu bar links

Home > What's New > The Chairman of the Board accepted a Voluntary Compliance Undertaking (VCU) for Xarelto

Institutional links

About PMPRB
Frequently Asked Questions
Frequently Requested Items
Legislation, Regulations and Guidelines
Regulatory
Regulatory Filings
Reporting
Consultations
Publications
Reports to Parliament

 

Hospitality and Travel Expenses
Contracts
Disclosure of Position Reclassifications
Grant and Contribution Awards Over $25,000

January 22, 2010

The Chairman of the Board accepted a Voluntary Compliance Undertaking (VCU) for Xarelto

The Chairman of the Board accepted a VCU (PDF) submitted by Bayer Inc. regarding the price of Xarelto.

BACK TO LISTINGS

Date Modified: 2010-07-16

Top of Page
Important Notices